Invention Grant
- Patent Title: Salt form of a human histone methyltransferase EZH2 inhibitor
-
Application No.: US17032432Application Date: 2020-09-25
-
Publication No.: US11491163B2Publication Date: 2022-11-08
- Inventor: Kevin Wayne Kuntz , Kuan-Chun Huang , Hyeong Wook Choi , Kristen Sanders , Steven Mathieu , Arani Chanda , Francis Fang
- Applicant: Epizyme, Inc. , Eisai R&D Management Co., Ltd.
- Applicant Address: US MA Cambridge; JP Tokyo
- Assignee: Epizyme, Inc.,Eisai R&D Management Co., Ltd.
- Current Assignee: Epizyme, Inc.,Eisai R&D Management Co., Ltd.
- Current Assignee Address: US MA Cambridge; JP Tokyo
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Christine E. Dunne
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D405/12
Abstract:
Provided herein is N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl (tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4′-(morpholinomethyl)-[1,1′-biphenyl]-3-carboxamide hydrobromide. Also provided herein is a particular polymorph form of this compound.
Public/Granted literature
- US20210137936A1 SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR Public/Granted day:2021-05-13
Information query
IPC分类:
